Leadership Transition Recent executive changes with Katharine McIntosh appointed CEO in June 2026 and prior appointment of Anna Tomlinson in February 2025 indicate active leadership evolution. Potential sales angle: offer strategic partnerships, fundraising or program expansion services aligned with a new leadership vision.

Digital Engagement Active online presence across multiple platforms (Instagram, YouTube, Drupal site, Google Analytics) plus a dedicated online support group. Opportunity for technology uplift, analytics-driven donor engagement, and digital fundraising campaigns using CRM, marketing automation, or content optimization.

Support Programs Extensive patient and professional support services, including nurse referrals, helplines, volunteer groups, and one-day events. Potential for scalable program delivery partnerships, training resources, and telehealth or e-learning platform enhancements.

Strategic Partnerships Recent collaborations with Marie Curie and planning for a genetic advice helpline signal openness to third-party alliances. Sales angle: co-branded education initiatives, palliative care integration, and joint funding applications or grant opportunities.

Growth & Funding Revenue under one million with a lean team (11-50 employees) and a history of expanding services. Market need in cardiomyopathy support suggests opportunity for scalable donor acquisition programs, grant consulting, and technology solutions to improve impact while maintaining cost efficiency.